Skip to content

Business wanted

Pharmaceutical Chemicals.

Reference: E001550 EXITS.co.uk are actively seeking a Pharmaceutical Chemicals business on behalf of a European Trade Buyer with US Private Equity Support.

Reference
E001550
Status
Active
Sector
health care life sciences
Reference
E001550
Status
Active
Jurisdiction
United Kingdom
Sector
health care life sciences
Published
Oct 14, 2025
Adviser
EXITS.co.uk

What is this listing?

An acquirer is actively seeking a business of this type. If your business fits the criteria, EXITS.co.uk can introduce you confidentially.

Reference: E001550 EXITS.co.uk are actively seeking a Pharmaceutical Chemicals business on behalf of a European Trade Buyer with US Private Equity Support. The acquirer is a well-established European group of chemical businesses, specialising in the production and supply of chemical products for the pharmaceutical industry.

Operating across multiple European locations, they serve a wide range of pharmaceutical clients and are committed to innovation, quality, and regulatory compliance. Backed by US private equity, they have the financial strength, industry expertise, and strategic focus to support the growth and expansion of the acquired company. Industry Focus: They are actively seeking to expand their presence in the pharmaceutical chemicals sector, with a specific interest in acquiring producers of active pharmaceutical ingredients (APIs), intermediates, and other speciality chemicals used in drug formulation and manufacturing.

Their aim is to enhance their production capabilities, broaden their product portfolio, and strengthen their supply position within the European pharmaceutical market. Target Market: The ideal acquisition targets are established producers of chemicals for the pharmaceutical industry, with proven expertise, robust manufacturing processes, and a track record of delivering consistent quality to pharmaceutical customers. Companies operating to stringent regulatory standards, such as GMP, and those with strong customer relationships in both branded and generic pharmaceutical sectors, will be of particular interest.

Financial Performance: They are seeking companies with an annual turnover in excess of £5 million. Targets should demonstrate financial stability, healthy profit margins, and sustainable growth potential. Key performance metrics include revenue trends, profitability, operational efficiency, and compliance history.

Geographic Location: The acquisition strategy is focused on companies located across Europe. Businesses with strategically positioned manufacturing facilities, established logistics networks, and the ability to serve international markets will be prioritised. The Next Steps: For further information or to discuss the potential opportunities, please contact info@exits.

EXITS.co.uk All Communication is Strictly Private & Confidential This is a confidential business acquisition requirement managed exclusively by EXITS.co.uk on behalf of a qualified buyer or investor. If you own or represent a business that fits this acquisition profile, we invite you to get in touch.

At EXITS.co.uk, we handle full and partial business sales, provide business valuations, assist with exit planning, and help you find suitable acquisition opportunities. Our confidential M&A matchmaking service ensures your privacy and security throughout the process.

Please note that charges may apply for formal engagements resulting in successful deals. Full terms of business are available upon request. Contact EXITS.co.uk to discuss the options open to you. First conversations are confidential and carry no obligation.